AI assistant
Sending…
Longeveron Inc. — Director's Dealing 2022
Apr 15, 2022
35052_dirs_2022-04-15_be8f14dc-348c-4da0-a9f0-ea24f806ff0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Longeveron Inc. (LGVN)
CIK: 0001721484
Period of Report: 2022-04-13
Reporting Person: DS MED LLC (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-13 | Common Stock | J | 748694 | — | Disposed | 7024208 | Direct |
Footnotes
F1: Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
F2: Shares distributed to members of DS Med, LLC, for no consideration.
More from Longeveron Inc.
Annual Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 20
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Apr 17
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 24